M.TUBERCULOSIS
Abbott RealTime MTB RIF/INH Resistance
For more information, contact Abbott.
For more information, contact Abbott.
| PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
|---|
The Abbott RealTime MTB RIF/INH Resistance assay provides qualitative resistance detection within a single assay for the two most important first-line M. tuberculosis (TB) drugs.
To learn more about Abbott RealTime MTB RIF/INH Resistance please visit: https://www.molecular.abbott/int/en/products/infectious-disease/realtime-mtb-rif-inh-resistance
| ABBOTT REALTIME MTB RIF/INH RESISTANCE | |
| Clinical sensitivity | Rifampicin 94.8%; isoniazid 88.3% |
| Clinical specificity | Rifampicin 100%; isoniazid 94.3% |
| Limit of Detection (LoD) | 60 CFU/mL (probit analysis 32.37 CFU/mL with 95% probability) |
| Target Region | Probes targeting rpoB for Rifampicin resistance and katG and inhA upper promoter region for Isoniazid resistance |
| Reported results | Rif R-, Rif R det; INH R-, INH High R, INH Low R (see package insert for further details) |
| Subspecies coverage | Eight members of MTB complex M. tuberculosis, M. africanum, M. bovis, M. bovis BCG, M. microti, M. caprae, M. pinnipedii, M. canetti |
| Internal control | Processed with each sample |
| Specimen type | Sputum or bronchial alveolar lavage, or the NALC sediment of sputum or bronchial alveolar lavage, or already extracted DNA of MTB-positive specimens |
| Input volume | 0.8 mL of inactivated specimen if extraction is needed, optional use of already extracted DNA of MTB-positive specimen |
| Sample preparation | Extraction: m2000sp or manual Optional use of automated reflex with m2000sp allows use of already extracted DNA of MTB-positive specimen |
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.